EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunoinformatics‐Driven Design of a Multi‐Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention

Roman Akbar, Shabeen Fatima, Siddiq Ur Rahman, Abdul Malik, Suhail Akhtar, Nikhat J Siddiqi, Sara Aiman iD, Kaisong Huang

Reviews in Medical Virology · 2025

DOI: 10.1002/rmv.70065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2025. Verfasst von Roman Akbar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science and Bioinformatics, Khushal Khan Khattak University, Karak, Pakistan. Hauptthemen laut MEDLINE: Capsid Proteins, Simian virus 40, Epitopes, T-Lymphocyte, Viral Vaccines. Die Arbeit nennt 88 Literaturangaben. Gefördert von: Ongoing Research Funding Program, Guangdong Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Simian Virus (SV) 40 is a DNA virus that remains dormant in the body but occasionally induces tumours in animals. Evidence indicates that SV40 could be crucial in developing certain human cancers. There is no commercial vaccine available against SV40. Our study uses a reverse vaccinology strategy to design a vaccine containing the viral Major capsid protein VP1 protein of the Simian virus's B and T‐cell epitopes. Eleven MHC‐I restricted, ten MHC‐II restricted, and five B‐cell specific epitopes were prioritised for the design of vaccine model, based on non‐allergenicity as a crucial feature and an antigenicity score of > 0.4. An immunogenic and stable vaccine design was generated using the 6‐histidine tag, including a 30S ribosomal protein AS04 as an adjuvant with linkers (EAAAK, GPGPG, and AYY). Highly broad‐spectrum vaccine was generated with 99.75% of global population coverage. Ramachandran score of 91.7% indicated the structural stability of the designed vaccine. The immunological simulations presented that a persistent antibody response occurred even if the antigen was expelled. IgM + IgG titres were predicted to rise to 6000 after 10 days of injection, and stabilised at 3000 after 30 days, suggesting that the vaccine is effective and provides long‐lasting protection against SV40. Molecular docking and MD simulation analyses were performed to study the stability and dynamic confirmation of the designed vaccine model and immune receptor (8JBV), validating strong molecular interactions, hence triggering innate and immune responses against the SV40. Further immunological assays are required to validate the results of this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Capsid ProteinsSimian virus 40Epitopes, T-LymphocyteViral VaccinesEpitopes, B-LymphocytePolyomavirus InfectionsTumor Virus InfectionsHumansAnimalsComputational BiologyAntibodies, ViralVaccinologyImmunoinformatics

Stichwörter der Autor:innen

immunoinformaticsmultiepitope vaccinereverse vaccinologysimian virusvaccine designing

Substanzen

Capsid ProteinsEpitopes, T-LymphocyteViral VaccinesEpitopes, B-LymphocyteAntibodies, ViralVP1 protein, polyomavirus

Autor:innen und Institutionen

  • Department of Computer Science and Bioinformatics, Khushal Khan Khattak University, Karak, Pakistan.
  • Institute of Inorganic Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • A.T. Still University of Health Sciences, Kirksville, Missouri, USA.
  • Department of Medical Surgical, College of Nursing, King Saud University, Riyadh, Saudi Arabia.
  • Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, China.

ORCID-Profile: Sara Aiman

Förderung

  • Ongoing Research Funding Program
  • Guangdong Medical University

Zitieren

APA

Akbar, R., Fatima, S., Rahman, S. U., Malik, A., Akhtar, S., Siddiqi, N. J., Aiman, S., & Huang, K. (2025). Immunoinformatics‐Driven Design of a Multi‐Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70065

Vancouver

Akbar R, Fatima S, Rahman SU, Malik A, Akhtar S, Siddiqi NJ, et al. Immunoinformatics‐Driven Design of a Multi‐Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention. Reviews in Medical Virology. 2025. doi:10.1002/rmv.70065

BibTeX
@article{Akbar2025,
  author = {Akbar, Roman and Fatima, Shabeen and Rahman, Siddiq Ur and Malik, Abdul and Akhtar, Suhail and Siddiqi, Nikhat J and Aiman, Sara and Huang, Kaisong},
  title = {Immunoinformatics‐Driven Design of a Multi‐Epitope Vaccine Targeting Simian Virus VP1 Major Capsid Protein for Oncogenic Viral Infection Prevention},
  journal = {Reviews in Medical Virology},
  year = {2025},
  doi = {10.1002/rmv.70065}
}
Kostenlos starten →